{"id":"W4402538375","doi":"10.1007/s10637-024-01461-z","title":"A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors","year":2024,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; MAPK/ERK pathway; Internal medicine; Pharmacology; Chemistry; Kinase; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001091957,0.000153817,0.0002334903,0.0001336999,0.00004788965,0.00001969794,0.0001101998,0.00003922433,0.00004466946],"category_scores_gemma":[0.00004528946,0.00009822514,0.00006430607,0.0006249237,0.0001638509,0.0001267117,0.00003178002,0.0001880967,0.000005741362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002097318,"about_ca_system_score_gemma":0.001096035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002438129,"about_ca_topic_score_gemma":0.00006906859,"domain_scores_codex":[0.9985721,0.00004415248,0.0003799486,0.0002570318,0.0005879686,0.000158781],"domain_scores_gemma":[0.9994491,0.0000524247,0.00009694671,0.0002227785,0.0000812841,0.00009743266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08954956,0.03971073,0.3652922,0.002443447,0.003823952,0.000349639,0.1691133,0.003439579,0.0848235,0.003781267,0.04626213,0.1914108],"study_design_scores_gemma":[0.2083792,0.01040525,0.7410882,0.005062025,0.0003220131,0.00003710401,0.003621413,0.001232445,0.0219463,0.002213486,0.004939424,0.0007532263],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967935,0.0002756504,0.000002989573,0.00135886,0.0002486617,0.0009554428,0.0000244765,0.00003478066,0.000305639],"genre_scores_gemma":[0.9985539,0.00000314567,0.000130085,0.0005651612,0.0001190967,0.00004262715,0.00003347174,0.00002412573,0.0005284102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.375796,"threshold_uncertainty_score":0.4005505,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01090793660721727,"score_gpt":0.2797415372715782,"score_spread":0.2688336006643609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}